Japanese‐originated pharmaceutical products in the United States from 1960 to 1989: An assessment of innovation

@article{Hawkins1992JapaneseoriginatedPP,
  title={Japanese‐originated pharmaceutical products in the United States from 1960 to 1989: An assessment of innovation},
  author={E. A. Hawkins and M. Reich},
  journal={Clinical Pharmacology & Therapeutics},
  year={1992},
  volume={51}
}
  • E. A. Hawkins, M. Reich
  • Published 1992
  • Medicine
  • Clinical Pharmacology & Therapeutics
  • Clinical Pharmacology and Therapeutics(1992) 51, 1–11; doi:10.1038/clpt.1992.1 
    13 Citations

    Topics from this paper.

    Innovation management of Japanese pharmaceutical companies: the case of an antibiotic developed by Takeda
    • T. Hara
    • Computer Science, Economics
    • Int. J. Technol. Manag.
    • 2005
    • 2
    Technological change in the pharmaceutical industry in Japan and the United Kingdom
    Peripheral Opioid Modulation of Visceral Pain a
    • 26
    Die japanische Pharmaindustrie

    References

    SHOWING 1-10 OF 20 REFERENCES
    Biotechnology in pharmaceuticals: the Japanese challenge.
    • 16
    The Measurement of Pharmaceutical Innovation
    • 26
    The Measurement of Therapeutic Value
    • 13
    The Growth of Japanese Science and Technology
    • 53
    Competing in Japan
    • 4
    Guide No. BD 4821.3. Rockville, Maryland: FDA